The COVID-19 Pandemic – News and Features

Researchers have employed a cross-species immunological analysis to provide new insights into a smallpox vaccine's immunogenicity and safety against the monkeypox virus.

An AI model called EVE-Vax uses evolutionary, biological and structural information about a virus to predict and design surface proteins likely to occur as the pathogen mutates.

Researchers have traced a genetic mutation that provides HIV resistance to a person who lived near the Black Sea 6,700–9,000 years ago. The gene likely helped ancient humans survive disease as they transitioned to agricultural living.

University of Cincinnati engineers created a new device to help doctors diagnose depression and anxiety.

Researchers have embedded a breath sensor into a standard surgical mask to identify volatile metabolites associated with CKD, achieving promising diagnostic accuracy in initial tests.

The researchers argue that member states should harmonize policies, offer stronger incentives for drug development and streamline approval processes to make Europe a more attractive location for pharmaceutical companies.

An investigational gene therapy has successfully restored immune function in all nine children treated with the rare and life-threatening immune disorder called severe leukocyte adhesion deficiency-I, or LAD-I.

Researchers at Karolinska Institutet have identified biomarkers in the blood associated with symptoms of long COVID, particularly severe respiratory disorders. The discovery can pave the way for future diagnosis and treatment.

This article explores how synthetic biology is revolutionizing therapeutics through engineered cells, precision genetic circuits and AI-driven design, with applications in cancer treatment, vaccine development and next-generation immunotherapies.

A new machine learning algorithm excels at interpreting optical spectroscopy data of molecules, materials and disease biomarkers, potentially enabling faster and more precise medical diagnoses and sample analysis.